SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Use of JMP® for Optimizing a Custom Peptide Microarray to Identify Autoantibodies for Multiple Sclerosis

About this paper

Design of experiment (DOE) was utilized to optimize a peptide microarray to test autoantibodies in serum against various components of the myelin sheath. Incorporating the ideal assay conditions from a single DOE experiment versus multiple sequential experiments resulted in a reproducible serum assay with low variability, low nonspecific background, and a high level of distinction between multiple sclerosis (MS) and normal samples. A minimum set of peptides was found that achieved a sensitivity of 90 percent. Autoantibodies against each individual peptide were elevated in at least 35 percent of the individual MS patients tested.

Sobre o SAS

SAS é o líder de mercado em Analytics. Por meio de soluções analíticas inovadoras, voltadas para a inteligência do negócio e gerenciamento de dados, a companhia ajuda seus clientes em mais de 75.000 localidades a tomarem decisões de forma rápida e assertiva. Desde 1976, o SAS fornece aos clientes ao redor do mundo THE POWER TO KNOW® (O Poder do Conhecimento).

Já tem um Perfil SAS? Realize o preenchimento automático deste formulário. Entrar

*
*
*
*
 
*
*
 
 

Back to Top